Significant Reduction in Helicobacter pylori Load in Humans with Non-viable Lactobacillus reuteri DSM17648: A Pilot Study.
Reducing the amount of Helicobacter pylori in the stomach by selective bacterial–bacterial cell interaction was sought as an effective and novel method for combating the stomach pathogen. Lactobacillus reuteri DSM17648 was identified as a highly specific binding antagonist to H. pylori among more than 700 wild-type strains of Lactobacillus species.
C. Holz, A. Busjahn, H. Mehling, S. Arya, M. Boettner, H. Habibi, C. Lang (2014)
Probiotics & Antimicro. Prot. 7: 91-100